Log in to save to my catalogue

DNA replication during acute MEK inhibition drives acquisition of resistance through amplification o...

DNA replication during acute MEK inhibition drives acquisition of resistance through amplification o...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2504847085

DNA replication during acute MEK inhibition drives acquisition of resistance through amplification of the BRAF oncogene

About this item

Full title

DNA replication during acute MEK inhibition drives acquisition of resistance through amplification of the BRAF oncogene

Publisher

Cold Spring Harbor: Cold Spring Harbor Laboratory Press

Journal title

bioRxiv, 2021-10

Language

English

Formats

Publication information

Publisher

Cold Spring Harbor: Cold Spring Harbor Laboratory Press

More information

Scope and Contents

Contents

Mutations and gene amplifications that confer drug resistance emerge frequently during chemotherapy, but their mechanism and timing is poorly understood. Here, we investigate BRAFV600E amplification events that underlie resistance to the MEK inhibitor selumetinib (AZD6244/ARRY-142886) in COLO205 cells, a well-characterised model for reproducible em...

Alternative Titles

Full title

DNA replication during acute MEK inhibition drives acquisition of resistance through amplification of the BRAF oncogene

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2504847085

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2504847085

Other Identifiers

E-ISSN

2692-8205

DOI

10.1101/2021.03.23.436572